REQUEST A DEMO
Total
USD $0.00
Search more companies

Klinika Leczenia Zyl - Orawczyk Sp. z o.o. (Poland)

Main Activities: Ambulatory Health Care Services
Secondary Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | Offices of Physicians
Full name: Klinika Leczenia Zyl - Orawczyk Sp. z o.o. Profile Updated: April 03, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Klinika Leczenia Zyl - Orawczyk Sp. z o.o. is a company in Poland, with a head office in Nowy Sacz. The company operates in the Ambulatory Health Care Services industry. It was incorporated on January 14, 2022. From the latest financial highlights, Klinika Leczenia Zyl - Orawczyk Sp. z o.o. reported a net sales revenue increase of 51.99% in 2023. During that time, Klinika Leczenia Zyl - Orawczyk Sp. z o.o.’s total assets decreased by 15.26%.

Headquarters
Ul. Jana Kilinskiego 80
Nowy Sacz; Malopolskie; Postal Code: 33-300

Contact Details: Purchase the Klinika Leczenia Zyl - Orawczyk Sp. z o.o. report to view the information.

Website: http://www.orawczyk.com

Basic Information
Registered Capital:
Purchase the Klinika Leczenia Zyl - Orawczyk Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Klinika Leczenia Zyl - Orawczyk Sp. z o.o. report to view the information.
Incorporation Date:
January 14, 2022
Company Performance
Financial values in the chart are available after Klinika Leczenia Zyl - Orawczyk Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
51.99%
Total Operating Revenue
46.58%
Operating Profit
N/A
EBITDA
N/A
Net Profit/Loss for the Period
N/A
Total Assets
-15.26%
Total Equity
N/A
Operating Profit Margin
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
71.79%
Quick Ratio
-0.02%
Cash Ratio
-0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?